The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease

Table 3

Comparison of improving SF-36 scores between GERD and non-GERD patients after one-week and two-week therapy.

	One week after therapy			Two weeks after therapy
			P value			𝑃 value
	GERD	Non-GERD		GERD	Non-GERD
A group	129.76±44.84	10.52±20.19	𝑃<0.00	181.10±79.09	43.26±30.40	<0.00
B group	144.26±60.37	73.88±38.88	𝑃=0.031	144.26±60.37	73.88±38.88	0.038
C group	114.88±49.77	72.22±63.11	𝑃=0.085	185.59±73.55	102.55±98.78	0.028